Bioxytran
-
Bioxytran Announces Breakthrough Precision Diagnostics for Tissue Oxygenation
Bioxytran’s (BIXT) is advancing tissue-specific oxygen monitoring with the publication of research by Prof. Mayevsky. The research addresses limitations of current oxygen measurements and aims to revolutionize treatment for conditions like stroke and Alzheimer’s. Bioxytran’s MDX Viewer technology and BXT-25 program will serve as a crucial biomarker in clinical trials, potentially transforming oxygen delivery management. The technology targets a shift from peripheral to tissue-specific oxygenation monitoring.
